08.11.2022 22:08:38
|
Novavax Inc. Q3 Loss decreases, but misses estimates
(RTTNews) - Novavax Inc. (NVAX) reported Loss for third quarter that decreased from the same period last year but missed the Street estimates.
The company's bottom line came in at -$168.61 million, or -$2.15 per share. This compares with -$322.43 million, or -$4.31 per share, in last year's third quarter.
Analysts on average had expected the company to earn $1.57 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 310.7% to $734.58 million from $178.84 million last year.
Novavax Inc. earnings at a glance (GAAP) :
-Earnings (Q3): -$168.61 Mln. vs. -$322.43 Mln. last year. -EPS (Q3): -$2.15 vs. -$4.31 last year. -Analyst Estimates: $1.57 -Revenue (Q3): $734.58 Mln vs. $178.84 Mln last year.
-Guidance: Full year revenue guidance: $2.0 Bln
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novavax Inc.mehr Nachrichten
11.11.24 |
Ausblick: Novavax präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) | |
08.08.24 |
Umsatz von Novavax fällt deutlich - Novavax-Aktie dennoch höher (finanzen.at) | |
07.08.24 |
Ausblick: Novavax zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) | |
06.06.24 |
Novavax-Aktie wechselt ins Negative: Empfehlung für Corona-Impfstoff stärkt Novavax (finanzen.at) |